Fred Hutchinson Cancer Research — Seattle, Washington

Fred Hutchinson Cancer Research is a clinical research site located in Seattle, Washington, United States 98109-1024.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Fred Hutchinson Cancer Research has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Acute Myeloid Leukemia, Relapsed Multiple Myeloma, Refractory Multiple Myeloma.

Sponsors: Amphivena Therapeutics, Inc., Takeda, Mesoblast, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Seattle

Browse all research sites in Washington · View every site in Seattle

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fred Hutchinson Cancer Research?

Fred Hutchinson Cancer Research has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fred Hutchinson Cancer Research conducted?

Fred Hutchinson Cancer Research has 4 clinical trials on record, with 1 currently active. Their work covers Acute Myeloid Leukemia, Relapsed Multiple Myeloma, Refractory Multiple Myeloma.

Is Fred Hutchinson Cancer Research accredited by Crixeo Clinical Trials?

Fred Hutchinson Cancer Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fred Hutchinson Cancer Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.